
Beam Therapeutics Inc.
BEAMHealthcare|Biotechnology|US
$26.41
+0.54 (+2.09%)
Tangible Book / Share
$9.10
Cash / Share
$9.97
Ownership Breakdown
85.3%
Float
103.3M
Shares Outstanding
88.1M
Float Shares
Major Holders (31)
Combined: 258.8%
Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.
| Holder | Type | % of Class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| Abigail P. Johnson | Individual | 12.60% | 12,750,369 | Feb 5, 2026 | 13D/G |
| FMR LLC | Holding company | 12.60% | 12,750,369 | Feb 5, 2026 | 13D/G |
| Gehani, Varun N. | HC, IN | 9.99% | 10,282,210 | Aug 13, 2026 | 13D/G |
| Dunn Hannah E. | HC, IN | 9.99% | 10,282,210 | Aug 13, 2026 | 13D/G |
| Dreyfuss, Philip D. | HC, IN | 9.99% | 10,282,210 | Aug 13, 2026 | 13D/G |
| Kim, David T. | HC, IN | 9.99% | 10,282,210 | Aug 13, 2026 | 13D/G |
| Giauque, Nicolas | HC, IN | 9.99% | 10,282,210 | Aug 13, 2026 | 13D/G |
| Farallon Capital Management, L.L.C. | IA, OO | 9.99% | 10,282,210 | Aug 13, 2026 | 13D/G |
| Linn, Michael G. | HC, IN | 9.99% | 10,282,210 | Aug 13, 2026 | 13D/G |
| Husen, Avner A. | HC, IN | 9.99% | 10,282,210 | Aug 13, 2026 | 13D/G |
| Dapice Joshua J. | HC, IN | 9.99% | 10,282,210 | Aug 13, 2026 | 13D/G |
| Wehrly, Mark C. | HC, IN | 9.99% | 10,282,210 | Aug 13, 2026 | 13D/G |
| Warren, John R. | HC, IN | 9.99% | 10,282,210 | Aug 13, 2026 | 13D/G |
| Spokes, Andrew J. M. | HC, IN | 9.99% | 10,282,210 | Aug 13, 2026 | 13D/G |
| Short Daniel S. | HC, IN | 9.99% | 10,282,210 | Aug 13, 2026 | 13D/G |
| Saito Edric C. | HC, IN | 9.99% | 10,282,210 | Aug 13, 2026 | 13D/G |
| Roberts, Jr., Thomas G. | HC, IN | 9.99% | 10,282,210 | Aug 13, 2026 | 13D/G |
| Luo Patrick (Cheng) | HC, IN | 9.99% | 10,282,210 | Aug 13, 2026 | 13D/G |
| Catherine D. Wood | HC, IN | 9.95% | 10,234,862 | Aug 14, 2026 | 13D/G |
| ARK Investment Management LLC | Investment adviser | 9.95% | 10,234,862 | Aug 14, 2026 | 13D/G |
| BlackRock, Inc. | Holding company | 7.50% | 7,499,930 | Apr 17, 2025 | 13D/G |
| State Street Corporation | Holding company | 5.20% | 5,228,529 | Feb 9, 2026 | 13D/G |
| Vanguard Capital Management | Investment adviser | 5.02% | 5,122,475 | Apr 29, 2026 | 13D/G |
| Robert Nelsen | Individual | 4.60% | 4,600,747 | May 15, 2025 | 13D/G |
| Clinton Bybee | Individual | 4.50% | 4,550,630 | May 15, 2025 | 13D/G |
| Keith Crandell | Individual | 4.50% | 4,557,862 | May 15, 2025 | 13D/G |
| ARCH Venture Partners IX, LLC | Other | 4.50% | 4,540,132 | May 15, 2025 | 13D/G |
| ARCH Venture Partners IX Overage, L.P. | Partnership | 4.50% | 4,540,132 | May 15, 2025 | 13D/G |
| ARCH Venture Partners IX, L.P. | Partnership | 4.50% | 4,540,132 | May 15, 2025 | 13D/G |
| ARCH Venture Fund IX Overage, L.P. | Partnership | 4.50% | 4,540,132 | May 15, 2025 | 13D/G |
| ARCH Venture Fund IX, L.P. | Partnership | 4.50% | 4,540,132 | May 15, 2025 | 13D/G |
Insider Trades (100)
Last 4 quarters: 1,052,060 acquired · 1,018,017 disposed
| Insider | Position | Date | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Evans John M. | director, officer: CEO | Oct 16, 2026 | OPTION EX. | 25,000 | $1.03 | $25.8K | Form 4 |
| Evans John M. | director, officer: CEO | Oct 15, 2026 | SELL | 25,000 | $23.57 | $589.1K | Form 4 |
| Evans John M. | director, officer: CEO | Oct 16, 2026 | SELL | 25,000 | $23.98 | $599.6K | Form 4 |
| Evans John M. | director, officer: CEO | Oct 15, 2026 | OPTION EX. | 25,000 | $1.03 | $25.8K | Form 4 |
| Evans John M. | director, officer: CEO | Oct 16, 2026 | OPTION EX. | 25,000 | $1.03 | $25.8K | Form 4 |
| Cavanagh Bethany J | SVP, Finance and Treasurer | Oct 1, 2026 | SELL | 187 | $24.41 | $4.6K | Form 4 |
| Ciaramella Giuseppe | President | Sep 24, 2026 | GIFT | 123,407 | — | — | Form 4 |
| Simon Amy | Chief Medical Officer | Jul 27, 2026 | SELL | 16,667 | $25.74 | $429.0K | Form 4 |
| Simon Amy | Chief Medical Officer | Jun 30, 2026 | SELL | 373 | $34.73 | $13.0K | Form 4 |
| Evans John M. | director, officer: CEO | Jun 30, 2026 | OPTION EX. | 25,000 | $1.03 | $25.8K | Form 4 |
| Evans John M. | director, officer: CEO | Jun 29, 2026 | OPTION EX. | 18,663 | $0.67 | $12.5K | Form 4 |
| Evans John M. | director, officer: CEO | Jun 29, 2026 | SELL | 13,421 | $35.13 | $471.5K | Form 4 |
| Evans John M. | director, officer: CEO | Jun 30, 2026 | SELL | 23,100 | $34.26 | $791.5K | Form 4 |
| Evans John M. | director, officer: CEO | Jun 29, 2026 | SELL | 11,579 | $35.91 | $415.8K | Form 4 |
| Evans John M. | director, officer: CEO | Jun 30, 2026 | SELL | 1,900 | $34.84 | $66.2K | Form 4 |
| Evans John M. | director, officer: CEO | Jun 29, 2026 | OPTION EX. | 6,337 | $1.03 | $6.5K | Form 4 |
| Evans John M. | director, officer: CEO | Jun 30, 2026 | OPTION EX. | 25,000 | $1.03 | $25.8K | Form 4 |
| Evans John M. | director, officer: CEO | Jun 29, 2026 | OPTION EX. | 18,663 | $0.67 | $12.5K | Form 4 |
| FMR LLC | 10 percent owner, other: See Remark 1 | Jun 25, 2026 | SELL | 33,372 | $35.12 | $1.2M | Form 4 |
| FMR LLC | 10 percent owner, other: See Remark 1 | Jun 26, 2026 | SELL | 251,488 | $35.26 | $8.9M | Form 4 |
| Ciaramella Giuseppe | President | Jun 17, 2026 | OPTION EX. | 29,000 | $1.03 | $29.9K | Form 4 |
| Ciaramella Giuseppe | President | Jun 17, 2026 | OPTION EX. | 6,505 | $0.67 | $4.4K | Form 4 |
| Ciaramella Giuseppe | President | Jun 17, 2026 | OPTION EX. | 29,000 | $1.03 | $29.9K | Form 4 |
| Ciaramella Giuseppe | President | Jun 17, 2026 | OPTION EX. | 6,505 | $0.67 | $4.4K | Form 4 |
| Shaw Christi | director | Jun 3, 2026 | AWARD | 19,676 | $29.55 | $581.4K | Form 4 |
| Walsh Kathleen E | director | Jun 3, 2026 | AWARD | 19,676 | $29.55 | $581.4K | Form 4 |
| MARAGANORE JOHN | director | Jun 3, 2026 | AWARD | 19,676 | $29.55 | $581.4K | Form 4 |
| Fishman Mark | director | Jun 3, 2026 | AWARD | 19,676 | $29.55 | $581.4K | Form 4 |
| Guindo Chirfi | director | Jun 3, 2026 | AWARD | 19,676 | $29.55 | $581.4K | Form 4 |
| COOPER GRAHAM K | director | Jun 3, 2026 | AWARD | 19,676 | $29.55 | $581.4K | Form 4 |
| Evans John M. | director, officer: CEO | Apr 1, 2026 | SELL | 30,078 | $24.58 | $739.3K | Form 4 |
| Simon Amy | Chief Medical Officer | Apr 1, 2026 | SELL | 6,700 | $24.58 | $164.7K | Form 4 |
| Cavanagh Bethany J | SVP, Finance and Treasurer | Apr 1, 2026 | SELL | 3,242 | $24.58 | $79.7K | Form 4 |
| Bellon Christine | Chief Legal Officer | Apr 1, 2026 | SELL | 5,956 | $24.58 | $146.4K | Form 4 |
| Ciaramella Giuseppe | President | Apr 1, 2026 | SELL | 11,810 | $24.58 | $290.3K | Form 4 |
| Bellon Christine | Chief Legal Officer | Mar 31, 2026 | AWARD | 20,000 | — | — | Form 4 |
| Cavanagh Bethany J | SVP, Finance and Treasurer | Mar 31, 2026 | AWARD | 20,000 | — | — | Form 4 |
| Simon Amy | Chief Medical Officer | Mar 31, 2026 | AWARD | 31,750 | — | — | Form 4 |
| Emany Sravan Kumar | Chief Financial Officer | Mar 31, 2026 | AWARD | 31,750 | — | — | Form 4 |
| Ciaramella Giuseppe | President | Mar 31, 2026 | AWARD | 40,000 | — | — | Form 4 |
| Evans John M. | director, officer: CEO | Mar 31, 2026 | AWARD | 90,000 | — | — | Form 4 |
| Evans John M. | director, officer: CEO | Mar 31, 2026 | OPTION EX. | 25,000 | $0.67 | $16.8K | Form 4 |
| Evans John M. | director, officer: CEO | Mar 30, 2026 | SELL | 25,000 | $22.37 | $559.2K | Form 4 |
| Evans John M. | director, officer: CEO | Mar 31, 2026 | SELL | 25,000 | $22.76 | $569.1K | Form 4 |
| Evans John M. | director, officer: CEO | Mar 30, 2026 | OPTION EX. | 25,000 | $0.67 | $16.8K | Form 4 |
| Evans John M. | director, officer: CEO | Mar 31, 2026 | OPTION EX. | 25,000 | $0.67 | $16.8K | Form 4 |
| Ciaramella Giuseppe | President | Feb 24, 2026 | OPTION EX. | 35,000 | $17.00 | $595.0K | Form 4 |
| Ciaramella Giuseppe | President | Feb 24, 2026 | OPTION EX. | 35,000 | $17.00 | $595.0K | Form 4 |
| Ciaramella Giuseppe | President | Feb 24, 2026 | SELL | 35,000 | $32.00 | $1.1M | Form 4 |
| Cavanagh Bethany J | SVP, Finance and Treasurer | Jan 31, 2026 | AWARD | 40,000 | $27.62 | $1.1M | Form 4 |
| Ciaramella Giuseppe | President | Jan 31, 2026 | AWARD | 80,000 | $27.62 | $2.2M | Form 4 |
| Emany Sravan Kumar | Chief Financial Officer | Jan 31, 2026 | AWARD | 63,500 | $27.62 | $1.8M | Form 4 |
| Bellon Christine | Chief Legal Officer | Jan 31, 2026 | AWARD | 40,000 | $27.62 | $1.1M | Form 4 |
| Evans John M. | director, officer: CEO | Jan 30, 2026 | OPTION EX. | 25,000 | $0.67 | $16.8K | Form 4 |
| Evans John M. | director, officer: CEO | Jan 29, 2026 | OPTION EX. | 19,336 | $0.67 | $13.0K | Form 4 |
| Evans John M. | director, officer: CEO | Jan 29, 2026 | SELL | 16,333 | $29.19 | $476.8K | Form 4 |
| Evans John M. | director, officer: CEO | Jan 30, 2026 | SELL | 22,094 | $28.27 | $624.7K | Form 4 |
| Evans John M. | director, officer: CEO | Jan 29, 2026 | SELL | 8,667 | $29.74 | $257.8K | Form 4 |
| Evans John M. | director, officer: CEO | Jan 30, 2026 | SELL | 2,906 | $29.00 | $84.3K | Form 4 |
| Evans John M. | director, officer: CEO | Jan 31, 2026 | AWARD | 180,000 | $27.62 | $5.0M | Form 4 |
| Evans John M. | director, officer: CEO | Jan 29, 2026 | OPTION EX. | 5,664 | $0.67 | $3.8K | Form 4 |
| Evans John M. | director, officer: CEO | Jan 30, 2026 | OPTION EX. | 25,000 | $0.67 | $16.8K | Form 4 |
| Evans John M. | director, officer: CEO | Jan 29, 2026 | OPTION EX. | 19,336 | $0.67 | $13.0K | Form 4 |
| Simon Amy | Chief Medical Officer | Jan 31, 2026 | AWARD | 88,500 | $27.62 | $2.4M | Form 4 |
| Cavanagh Bethany J | SVP, Finance and Treasurer | Jan 22, 2026 | SELL | 6,198 | $35.00 | $216.9K | Form 4 |
| Bellon Christine | Chief Legal Officer | Jan 22, 2026 | SELL | 1,371 | $34.00 | $46.6K | Form 4 |
| Cavanagh Bethany J | SVP, Finance and Treasurer | Jan 20, 2026 | SELL | 3,034 | $30.12 | $91.4K | Form 4 |
| Bellon Christine | Chief Legal Officer | Jan 15, 2026 | SELL | 2,111 | $33.62 | $71.0K | Form 4 |
| Bellon Christine | Chief Legal Officer | Jan 15, 2026 | SELL | 15,959 | $34.72 | $554.1K | Form 4 |
| Bellon Christine | Chief Legal Officer | Jan 15, 2026 | SELL | 559 | $35.40 | $19.8K | Form 4 |
| Emany Sravan Kumar | Chief Financial Officer | Dec 31, 2025 | SELL | 6,294 | $27.10 | $170.6K | Form 4 |
| Bellon Christine | Chief Legal Officer | Dec 31, 2025 | SELL | 1,254 | $27.10 | $34.0K | Form 4 |
| Simon Amy | Chief Medical Officer | Dec 31, 2025 | AWARD | 12,500 | — | — | Form 4 |
| FMR LLC | 10 percent owner, other: See Remark 1 | Oct 27, 2025 | SELL | 459 | $26.68 | $12.2K | Form 4 |
| FMR LLC | 10 percent owner, other: See Remark 1 | Oct 6, 2025 | GIFT | 1,232,434 | — | — | Form 4 |
| Cavanagh Bethany J | SVP, Finance and Treasurer | Oct 1, 2025 | SELL | 467 | $24.53 | $11.5K | Form 4 |
| Bellon Christine | Chief Legal Officer | Oct 1, 2025 | SELL | 373 | $24.53 | $9.1K | Form 4 |
| Evans John M. | director, officer: CEO | Oct 2, 2025 | OPTION EX. | 25,000 | $0.67 | $16.8K | Form 4 |
| Evans John M. | director, officer: CEO | Oct 2, 2025 | SELL | 25,000 | $24.63 | $615.7K | Form 4 |
| Evans John M. | director, officer: CEO | Oct 1, 2025 | SELL | 25,000 | $24.51 | $612.7K | Form 4 |
| Evans John M. | director, officer: CEO | Oct 1, 2025 | OPTION EX. | 25,000 | $0.67 | $16.8K | Form 4 |
| Evans John M. | director, officer: CEO | Oct 2, 2025 | OPTION EX. | 25,000 | $0.67 | $16.8K | Form 4 |
| FMR LLC | 10 percent owner, other: See Remark 1 | Jul 30, 2025 | SELL | 48,374 | $20.50 | $991.7K | Form 4 |
| Simon Amy | Chief Medical Officer | Jul 1, 2025 | SELL | 374 | $16.94 | $6.3K | Form 4 |
| Simon Amy | Chief Medical Officer | Jul 3, 2025 | SELL | 876 | $20.12 | $17.6K | Form 4 |
| Walsh Kathleen E | director | Jun 4, 2025 | AWARD | 33,662 | $17.15 | $577.3K | Form 4 |
| Fishman Mark | director | Jun 4, 2025 | AWARD | 33,662 | $17.15 | $577.3K | Form 4 |
| Shaw Christi | director | Jun 4, 2025 | AWARD | 33,662 | $17.15 | $577.3K | Form 4 |
| Ho Carole | director | Jun 4, 2025 | AWARD | 33,662 | $17.15 | $577.3K | Form 4 |
| MARAGANORE JOHN | director | Jun 4, 2025 | AWARD | 33,662 | $17.15 | $577.3K | Form 4 |
| COOPER GRAHAM K | director | Jun 4, 2025 | AWARD | 33,662 | $17.15 | $577.3K | Form 4 |
| Guindo Chirfi | director | Jun 4, 2025 | AWARD | 33,662 | $17.15 | $577.3K | Form 4 |
| FMR LLC | 10 percent owner, other: See Remark 1 | Mar 31, 2025 | OTHER | 0 | — | — | Form 4 |
| FMR LLC | 10 percent owner, other: See Remark 1 | Mar 31, 2025 | OTHER | 0 | — | — | Form 4 |
| FMR LLC | 10 percent owner, other: See Remark 1 | Mar 31, 2025 | OTHER | 0 | — | — | Form 4 |
| Bellon Christine | Chief Legal Officer | Apr 1, 2025 | SELL | 5,674 | $18.35 | $104.1K | Form 4 |
| Evans John M. | director, officer: CEO | Apr 1, 2025 | SELL | 30,663 | $18.35 | $562.7K | Form 4 |
| Ciaramella Giuseppe | President | Apr 1, 2025 | SELL | 7,434 | $18.35 | $136.4K | Form 4 |
| Cavanagh Bethany J | SVP, Finance and Treasurer | Apr 1, 2025 | SELL | 3,015 | $18.35 | $55.3K | Form 4 |
| Simon Amy | Chief Medical Officer | Apr 1, 2025 | SELL | 9,566 | $18.35 | $175.5K | Form 4 |